JPS5594934A - Peptide type polymer and pharmaceutic composition containing it - Google Patents

Peptide type polymer and pharmaceutic composition containing it

Info

Publication number
JPS5594934A
JPS5594934A JP198080A JP198080A JPS5594934A JP S5594934 A JPS5594934 A JP S5594934A JP 198080 A JP198080 A JP 198080A JP 198080 A JP198080 A JP 198080A JP S5594934 A JPS5594934 A JP S5594934A
Authority
JP
Japan
Prior art keywords
residues
peptide
acid
lysine
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP198080A
Other languages
English (en)
Inventor
Rufuranshie Pieeru
Paran Moniiku
Odeibeeru Furansowaazu
Shiedeitsudo Riyui
Shiyoai Jiyan
Zera Mikaeru
Rudoore Edogiyaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of JPS5594934A publication Critical patent/JPS5594934A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/29—Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Polyamides (AREA)
JP198080A 1979-01-12 1980-01-11 Peptide type polymer and pharmaceutic composition containing it Pending JPS5594934A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7900819A FR2446292A1 (fr) 1979-01-12 1979-01-12 Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant

Publications (1)

Publication Number Publication Date
JPS5594934A true JPS5594934A (en) 1980-07-18

Family

ID=9220713

Family Applications (1)

Application Number Title Priority Date Filing Date
JP198080A Pending JPS5594934A (en) 1979-01-12 1980-01-11 Peptide type polymer and pharmaceutic composition containing it

Country Status (9)

Country Link
US (1) US4401659A (ja)
EP (1) EP0013651B1 (ja)
JP (1) JPS5594934A (ja)
AT (1) ATE3773T1 (ja)
DE (1) DE3063712D1 (ja)
DK (1) DK12780A (ja)
ES (1) ES8107247A1 (ja)
FR (1) FR2446292A1 (ja)
IE (1) IE49045B1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
FR2533827A1 (fr) * 1982-09-30 1984-04-06 Anvar Composition possedant des proprietes immunoregulatrices, notamment d'adjuvants immunologiques non specifiques, a base de muramylpeptide et d'un derive d'aluminium
FR2546756B1 (fr) * 1983-06-03 1985-11-29 Centre Nat Rech Scient Nouveaux derives immunostimulants, leur preparation et leur application comme medicament
FR2583049B1 (fr) * 1985-06-10 1988-08-05 Anvar Produits resultant de la conjugaison d'un support macromoleculaire, d'un haptene et d'un muramyl-peptide par l'intermediaire d'un groupement substituant la partie saccharidique du muramyl-peptide et compositions selectivement immunogenes contenant ces produits
DK585886A (da) * 1985-12-24 1987-06-25 Takeda Chemical Industries Ltd Immunstimulerende middel og anvendelse deraf
US4950645A (en) * 1988-07-08 1990-08-21 Immunotherapeutics, Inc. Composition for macrophage activation
US5416070A (en) * 1988-07-08 1995-05-16 Immunotherapeutics, Inc. Composition for macrophage activation
IT1237903B (it) * 1989-12-14 1993-06-18 Medidom Lab Derivati semisintetici ad attivita' immunomodulante atti alla somminitrazione parenterale ed orale
FR2692149B1 (fr) * 1992-06-12 1995-06-09 Vacsyn France Sa Composition adjuvante de l'immunite humorale et a mediation cellulaire n'induisant pas de reponse vis-a-vis de determinants auto-antigeniques.
US6281191B1 (en) 1997-12-29 2001-08-28 Vladimir I. Slesarev Compositions and methods for treating hepatitis-C
US7625695B2 (en) * 2006-08-24 2009-12-01 Samsung Electronics Co., Ltd. Polymers for anti-reflective coatings, anti-reflective coating compositions and methods of forming a pattern using the same
WO2016130908A1 (en) * 2015-02-13 2016-08-18 The University Of Toledo Therapeutic polysaccharide midi-gagr and related materials and methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1155134B (de) * 1958-06-07 1963-10-03 Hoechst Ag Verfahren zur Herstellung von Blutplasmaersatzmitteln aus Kollagenabbauprodukten
CH564031A5 (ja) * 1968-03-29 1975-07-15 Anvar
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
DE2450955C2 (de) * 1974-10-26 1976-09-29 Ofenbaugesellschaft Berg & Co Verfahren und Vorrichtung zum Patentleren von zu Bunden gehaspeltem Stahldraht
FR2321896A1 (fr) * 1975-08-29 1977-03-25 Anvar Agents adjuvants immunologiques actifs en solution aqueuse
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
US4082736A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
FR2358159A1 (fr) * 1976-07-16 1978-02-10 Anvar Le diamide de l'acide 2-(2-acetamido-2-deoxy-3 - o-d-glucopyranosyl) - d-propionyl-l-alanyl-d-glutamique et medicaments le contenant
EP0003833B2 (de) * 1978-02-24 1990-12-19 Ciba-Geigy Ag Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
US4401659A (en) 1983-08-30
DE3063712D1 (en) 1983-07-21
EP0013651A1 (fr) 1980-07-23
IE49045B1 (en) 1985-07-10
IE800053L (en) 1980-07-12
ES487926A0 (es) 1980-12-16
EP0013651B1 (fr) 1983-06-15
DK12780A (da) 1980-07-13
ATE3773T1 (de) 1983-06-15
FR2446292A1 (fr) 1980-08-08
FR2446292B1 (ja) 1983-01-07
ES8107247A1 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
ATE108662T1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
JPS5594934A (en) Peptide type polymer and pharmaceutic composition containing it
HK1021824A1 (en) Compositions and methods for treating infections using analogues of indolicidin
CA2153789A1 (en) Biologically active tgf-.beta.1 and tgf-.beta.2 peptides
CA2265900A1 (en) Improved solid-phase peptide synthesis and agent for use in such synthesis
EP0873754A4 (en) AMINO ACID COMPOSITIONS
WO1995003327A3 (en) Peptides for neutralizing the toxicity of lipid a
WO1997031019B1 (en) Antipathogenic peptides and compositions comprising them
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
ATE118686T1 (de) Biologisch wirksame polymere arzneistoffderivate.
ES2038675T3 (es) Un procedimiento para preparar compuestos peptidicos.
König et al. The amino acid sequence of the peptide moiety of the pseudomurein from Methanobacterium thermoautotrophicum
ATE242202T1 (de) Peptide
CA2067901A1 (en) Novel polypeptides with affinity to lipopolysaccharides and their uses
ATE30919T1 (de) Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
KR890013061A (ko) 폴리펩티드 유도체
GR3017297T3 (en) Novel substrate peptides.
NZ335136A (en) Isolated peptides which complex with hla-cw*16 molecules, and uses thereof
Harada et al. Characterization of functional groups of acidic thermal polymers of α-amino acids
TR199901831T2 (xx) Kollagen-II'ye �zg� bir T-h�cresi epitopundan olu�an peptitler.
SE9402253D0 (sv) Process
AR009805A1 (es) Peptidos que contienen cisteina
TH27915B (th) การปรับปรุงความสามารถที่จะทนทานได้ของกรด(สูตร)- อะมิโนที่ออกฤทธิ์ทางเภสัชกรรม
ES345040A2 (es) Procedimiento para la obtencion de peptidos con efecto acth.
RU2005106244A (ru) Связывающие молекулы